Logo Image
News
All NewsFDA UpdatesPress Releases
Watch
Expert ConversationsNews & AnalysisShows & PodcastsSponsored Webcast
Conferences
Conference CoverageConference Listing
Publications
All PublicationsPharmacy TimesPharmacy Practice in Focus: OncologyPharmacy Practice in Focus: Health SystemsPharmacy CareersAuthor SubmissionSubmit to Pharmacy Practice in Focus: OncologySubmit to Pharmacy Practice in Focus: Health SystemsBecome a Peer ReviewerSupplements & Featured Publications
More
Events
Upcoming EventsUpcoming Webinars
CE
Resources
Clinical ForumAmerican Heart MonthThe Bispecifics NetworkEducated PatientInformation for the PharmacistInteractive ToolsMicrositesPartnersPulsePointSponsoredWhiteboards

Subscribe

  • News
  • Watch
  • Conferences
  • Publications
  • Events
  • CE
  • Resources
  • Subscribe
  • 503B Compounding Pharmacy
  • Allergy
    • Asthma
  • Biosimilars
  • Cardiovascular Health
    • Heart Failure
    • Cholesterol
  • Chronic Kidney Disease
  • Classical Hematology
    • Immunoglobulins
    • Neutropenia
  • Dermatology
    • Psoriasis
    • Atopic Dermatitis
  • Endocrinology
    • Continuous Glucose Monitoring
    • Diabetes Awareness Month
    • Diabetes
    • Osteoporosis
  • Eye Care
    • Macular Degeneration
    • Dry Eye Disease
  • Future of Pharmacy
  • Gastrointestinal Health
    • Digestive Health
  • Hematology
    • Multiple Myeloma
    • Lymphoma
    • Myelofibrosis
    • Chronic Lymphocytic Leukemia
  • Hepatitis/MASH
  • Infectious Disease
    • Respiratory Syncytial Virus
    • Pneumococcal
    • C. difficile
    • COVID-19
    • Flu
    • HIV
    • PrEP
    • COVID Treatment
  • Neurology
    • Multiple Sclerosis
    • Alzheimer Disease
    • Epilepsy
    • Migraine
    • Sleep
    • Shingles
    • Alzheimer Disease
    • Movement Disorders
    • Parkinson Disease
  • Oncology
    • Cholangiocarcinoma
    • Endometrial Cancer
    • Immuno-oncology
    • Genitourinary Cancer
    • Lung Cancer
    • Prostate Cancer
    • Skin Cancer
    • Ovarian Cancer
    • Breast Cancer
    • Cervical Cancer
    • Gastrointestinal Cancer
    • Colorectal Cancer
    • HER2 Breast Cancer
  • Pain Management
  • Pediatrics
  • Psychiatry
    • Psychedelics
    • Schizophrenia
    • ADHD
    • Brain Health
    • Mental Health
    • Bipolar Disorder
    • Anxiety
    • Depression
  • Pulmonology
    • COPD
    • Cough and Cold
  • Rheumatology
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
  • Vaccines
    • Travel Vaccines
  • Veterinary Pharmacy
  • Vitamins and Supplements
  • Weight Management
  • Women's Health
    • Reproductive Health
Spotlight -
Community/Retail|
Health Systems|
Oncology|
Pharmacy Technician|
Student
Advertisement

Janine G. Martino, PharmD, BCOP, APh

Advertisement

Articles by Janine G. Martino, PharmD, BCOP, APh

Pharmacy technician performing aseptic drug compounding | Image Credit: © ultramansk - stock.adobe.com

Advancing the Role of Pharmacy Technicians in Hazardous Drug Compounding

ByJanine G. Martino, PharmD, BCOP, APh,Jaclyn M. Jaskowiak, PharmD, BCPS, BCSCP,Elaine Lu, CPhT
December 18th 2025

Pharmacy technicians enhance safety and efficiency in hazardous drug compounding.

Patient receiving chemotherapy -- Image credit: Andrey Popov | stock.adobe.com

Assessing Prescriber Justification for Use of Outpatient Chemotherapy in the Acute Care Setting

ByJanine G. Martino, PharmD, BCOP, APh,Kaitlyn Wells, PharmD,Sam Martinez, PharmD, BCOP, BCPS,Craig A. Stevens, PharmD, BCPS
June 17th 2025

Peer Reviewed

This single-center, descriptive, retrospective chart review identified barriers to outpatient chemotherapy use, revealing avoidable inpatient stays and highlighting targets for stewardship interventions.

Advertisement

Latest Updated Articles

  • Pharmacy technician performing aseptic drug compounding | Image Credit: © ultramansk - stock.adobe.com
    Advancing the Role of Pharmacy Technicians in Hazardous Drug Compounding

    December 18th 2025



Advertisement
Advertisement

Trending on Pharmacy Times

1

Asundexian Receives FDA Approval, Becomes First FXIa Inhibitor for Secondary Stroke Risk Reduction

2

FDA Requires Class-Wide GLP-1 RA Labeling Changes for Potential NAION Risk

3

mRNA vs Protein-Based COVID-19 Vaccines: What Pharmacists Can Tell Patients

4

Lilly–Hims & Hers GLP-1 Deal Tests Whether Convenience Can Deliver Continuity of Care

5

Oral PCSK9 Inhibitor Enlicitide Sustains LDL-C Reductions

  • About Us
  • Clinical Forums
  • Advertise
  • Contact Us
  • Editorial Staff
  • Privacy Policy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

  • Contemporary Clinic
  • OTC Guide
  • Pharmacy Times
  • Pharmacist Mom's Group
  • Pharmacist Mom's Group
Pharmacy Times
Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us